Therapeutic Targeting of Th17/Tc17 Cells Leads to Clinical Improvement of Lichen Planus
Farzan Solimani(Philipps University of Marburg), Michael Hertl(Philipps University of Marburg)
Cited by 115
Related Papers
T Cell Recognition of Desmoglein 3 Peptides in Patients with Pemphigus Vulgaris and Healthy Individuals
|The Journal of Immunology|2004|119
TH1/TH17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planus
|Journal of Allergy and Clinical Immunology|2018|83